Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

National Healthcare Properties (HLTC) EBITDA (2016 - 2025)

Historic EBITDA for National Healthcare Properties (HLTC) over the last 13 years, with Q3 2025 value amounting to -$17.8 million.

  • National Healthcare Properties' EBITDA rose 6729.46% to -$17.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$72.3 million, marking a year-over-year increase of 6889.94%. This contributed to the annual value of -$210.3 million for FY2024, which is 11128.46% down from last year.
  • As of Q3 2025, National Healthcare Properties' EBITDA stood at -$17.8 million, which was up 6729.46% from -$26.4 million recorded in Q2 2025.
  • In the past 5 years, National Healthcare Properties' EBITDA ranged from a high of $3.6 million in Q1 2021 and a low of -$121.2 million during Q2 2024
  • Its 5-year average for EBITDA is -$24.9 million, with a median of -$17.8 million in 2021.
  • As far as peak fluctuations go, National Healthcare Properties' EBITDA soared by 10583.14% in 2021, and later tumbled by 456168.22% in 2023.
  • National Healthcare Properties' EBITDA (Quarter) stood at -$14.6 million in 2021, then tumbled by 65.96% to -$24.3 million in 2022, then tumbled by 65.48% to -$40.1 million in 2023, then skyrocketed by 54.92% to -$18.1 million in 2024, then rose by 1.86% to -$17.8 million in 2025.
  • Its EBITDA stands at -$17.8 million for Q3 2025, versus -$26.4 million for Q2 2025 and -$10.0 million for Q1 2025.